脂水世界联盟关于脂水的定义和管理的基于德尔菲共识的立场文件:2023年在波茨坦举行的脂水世界大会的结果
Philipp Kruppa1, Rachelle Crescenzi2,3, Gabriele Faerber4
1Department of Plastic, Aesthetic and Reconstructive Microsurgery/Hand surgery, Hospital Ernst von Bergmann, Potsdam, Germany. kruppaph@gmail.com.
Nature communications
|January 10, 2026
概括
影响女性的脂质现在在定义和治疗方面达成了国际共识. 这项研究建立了一个改善全球患者护理的框架,并突出了需要进一步研究的领域.
科学领域:
- 医学科学 医学科学 医学科学
- 妇女健康 妇女健康
- 脂肪组织疾病 脂肪组织疾病
背景情况:
- 脂水主要影响女性,导致脂肪组织分布异常和不适.
- 不一致的诊断标准和治疗阻碍了唇的护理和研究.
- 全球需要就脂水的基本方面达成共识.
研究的目的:
- 为了达成国际共识,定义和管理的唇.
- 建立一个框架,以指导全球的唇水护理建议.
- 识别研究缺口,促进在唇研究中的合作.
主要方法:
- 一个多阶段的Delphi研究,涉及来自19个国家的国际专家.
- 在线调查和面对面的讨论被用来评估62个陈述.
- 专家评估的重点是清晰度,协议,证据和研究需求.
主要成果:
- 在与脂质有关的八个领域的59个陈述达成共识.
- 该研究为国际唇建议提供了基础框架.
- 确定了需要进一步研究和证据生成的关键领域.
结论:
- 建立的共识为指导国际唇管理提供了一个框架.
- 解决有限的证据对于改善全球唇患者的治疗结果至关重要.
- 国际合作对于有效解决妇女健康差异至关重要.
相关概念视频
Peripheral Artery Disease IV: Nursing Management
339
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
339
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
343
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
343
Peripheral Artery Disease III: Interprofessional Care
232
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
232
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Peripheral Artery Disease V: Postoperative Nursing Management
365
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
365
Phosphoinositides and PIPs
10.0K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.0K


